The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
about
The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE
@nl
The genetic variants in the PT ...... cancer and clinical outcomes.
@en
type
label
The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE
@nl
The genetic variants in the PT ...... cancer and clinical outcomes.
@en
prefLabel
The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE
@nl
The genetic variants in the PT ...... cancer and clinical outcomes.
@en
P2093
P2860
P356
P1433
P1476
The genetic variants in the PT ...... cancer and clinical outcomes.
@en
P2093
Ruishan Zhang
Zhuangkai Liu
P2860
P304
20252-20265
P356
10.18632/ONCOTARGET.15690
P407
P577
2017-03-01T00:00:00Z